CRISPR Therapeutics
CRSP
CRSP
179 hedge funds and large institutions have $1.01B invested in CRISPR Therapeutics in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
7% less capital invested
Capital invested by funds: $1.09B → $1.01B (-$78.9M)
57% less call options, than puts
Call options by funds: $20.2M | Put options by funds: $46.7M
Holders
179
Holding in Top 10
4
Calls
$20.2M
Puts
$46.7M
Top Buyers
| 1 | +$44.4M | |
| 2 | +$43.7M | |
| 3 | +$24M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$22.2M |
| 5 |
Two Sigma Investments
New York
|
+$15.7M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$10.8M | |
| 3 | -$10.6M | |
| 4 |
Renaissance Technologies
New York
|
-$10.1M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$8.11M |